Concerning MTC, there is evidence, as obtained by the dPCR Cote paper [51], of a direct prognostic impact for the cfDNA RET M918T mutation, which, when detected at the somatic level, is related to higher rates of metastasis and death [59]. Here, RET is linked to medullary thyroid gland carcinoma.